Cargando…
Diabetes, Heart Failure, and COVID-19: An Update
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a pandemic by the WHO in March 2020. As of August 2021, more than 220 countries have been affected, accounting for 211,844,613 confirmed cases and 4,432,802 deaths worldwide. A new delta variant wave is sweeping thro...
Autores principales: | Hebbard, Carleigh, Lee, Brooke, Katare, Rajesh, Garikipati, Venkata Naga Srikanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554151/ https://www.ncbi.nlm.nih.gov/pubmed/34721055 http://dx.doi.org/10.3389/fphys.2021.706185 |
Ejemplares similares
-
Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy
por: Rai, Amit K., et al.
Publicado: (2021) -
Elucidating the Functions of Non-Coding RNAs from the Perspective of RNA Modifications
por: Garikipati, Venkata Naga Srikanth, et al.
Publicado: (2021) -
Progressive Decrease in Coronary Vascular Function Associated With Type 2 Diabetic Heart Disease
por: Katare, Rajesh, et al.
Publicado: (2018) -
Long non-coding RNA lnc-CHAF1B-3 as a new player in fibrosis
por: Sen, Ilayda, et al.
Publicado: (2023) -
Isolation and characterization of mesenchymal stem cells from human fetus heart
por: Garikipati, Venkata Naga Srikanth, et al.
Publicado: (2018)